Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

Autor:	Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Carsten Schwarz
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	gastrointestinal patient reported outcome measure CFTR modulators elexacaftor symptom score Therapeutics. Pharmacology RM1-950
Zdroj:	Frontiers in Pharmacology, Vol 14 (2023)
Druh dokumentu:	article
ISSN:	1663-9812
DOI:	10.3389/fphar.2023.1207356
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/fdf445ccbf604305b8dbc4b1e0461e15 Zobrazit plný text záznamu View record in DOAJ